AUPH vs AVB · P/E 28, rev $160.9M vs P/E 23, rev $2.91B
Aurinia Pharmaceuticals Inc (AUPH) versus AvalonBay Communities Inc (AVB) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
AvalonBay Communities Inc (AVB) is a reit - residential company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
Latest reported AVB revenue for 2024-12-31 was $2.91B. Net income was $1.08B. Revenue was up 5.3% from 2023-12-31 to 2024-12-31. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. AVB currently screens at market cap $26.84B and trailing P/E 23.4.
Not investment advice. Open the AUPH and AVB stock pages for the full models.
Not investment advice.